kr101.60
1.20% yesterday
Copenhagen, Oct 15, 04:59 pm CET
ISIN
DK0060946788
Symbol
AMBU B

Ambu Stock price

kr101.60
+4.25 4.37% 1M
-16.30 13.83% 6M
-2.40 2.31% YTD
-26.40 20.63% 1Y
+26.60 35.47% 3Y
-92.90 47.76% 5Y
+62.70 161.18% 10Y
+96.40 1,853.85% 20Y
Copenhagen, Closing price Wed, Oct 15 2025
+1.20 1.20%
ISIN
DK0060946788
Symbol
AMBU B

Key metrics

Basic
Market capitalization
kr26.6b
Enterprise Value
kr26.4b
Net debt
positive
Cash
kr751.0m
Shares outstanding
266.4m
Valuation (TTM | estimate)
P/E
75.8 | 41.5
P/S
4.5 | 4.3
EV/Sales
4.4 | 4.3
EV/FCF
70.5
P/B
4.5
Dividends
DPS
kr0.38
Yield 1Y | 5Y
0.4% | 0.1%
Growth 1Y | 5Y
100.0% | 0.0%
Payout 1Y | 3Y
43.2% | 20.0%
Increased
1 Year
Financials (TTM | estimate)
Revenue
kr6.0b | kr6.1b
EBITDA
kr995.0m | kr1.2b
EBIT
kr784.0m | kr846.2m
Net Income
kr359.0m | kr652.3m
Free Cash Flow
kr375.0m
Growth (TTM | estimate)
Revenue
13.2% | 13.8%
EBITDA
22.8% | 29.1%
EBIT
31.8% | 31.2%
Net Income
-20.2% | 177.6%
Free Cash Flow
-38.9%
Margin (TTM | estimate)
Gross
59.9%
EBITDA
16.7% | 19.5%
EBIT
13.2%
Net
6.0% | 10.6%
Free Cash Flow
6.3%
Financial Health
Equity Ratio
78.2%
Return on Equity
4.2%
ROCE
12.3%
ROIC
11.6%
Debt/Equity
0.1
More
EPS
kr1.3
FCF per Share
kr1.4
Short interest
-
Employees
5k
Rev per Employee
kr1.1m
Show more

Is Ambu a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Ambu Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Ambu forecast:

8x Buy
62%
5x Hold
38%

Analyst Opinions

13 Analysts have issued a Ambu forecast:

Buy
62%
Hold
38%

Financial data from Ambu

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
5,958 5,958
13% 13%
100%
- Direct Costs 2,387 2,387
10% 10%
40%
3,571 3,571
15% 15%
60%
- Selling and Administrative Expenses 2,447 2,447
12% 12%
41%
- Research and Development Expense 129 129
22% 22%
2%
995 995
23% 23%
17%
- Depreciation and Amortization 211 211
2% 2%
4%
EBIT (Operating Income) EBIT 784 784
32% 32%
13%
Net Profit 359 359
20% 20%
6%

In millions DKK.

Don't miss a Thing! We will send you all news about Ambu directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.

Head office Denmark
CEO Britt Jensen
Employees 5,000
Founded 1937
Website www.ambu.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today